Scopus BioPharma
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Scopus BioPharma's balance sheet done over the years? Its assets were worth $392,265 last year, which is less than in the previous period. 1900% of Scopus BioPharma’s total assets is currently financed by debt. Its liabilities reached the amount of $7,454,434, which means an increase by 79% compared compared to last year.

Debt to Assets

Scopus BioPharma Inc. (NASDAQ:SCPS): Debt to assets
2017 212870 111.28K 52.28%
2018 132638 137.96K 104.02%
2019 771682 854.54K 110.74%
2020 1974068 3.80M 192.76%
2021 8187715 4.17M 50.93%
2022 392265 7.45M 1900.36%

SCPS Balance Sheet (2017 – 2022)

2022 2021 2020 2019 2018 2017
Assets
Current assets:
Cash and cash equivalents
124.57K7.94M1.83M36.74K1.66K158.21K
Short term investments
000000
Net receivables
00056227.85K54.65K
Inventory
000730.71K00
Other current assets
265.42K241.90M139.63K1103.11K0
Total current assets
390K8.18M1.97M768.02K132.63K212.87K
Non-current assets:
Property, Plant and Equipment
2.26K2.84K2.32K3.65K00
Goodwill
000000
Intangible assets
000000
Long term investments
000000
Other non-current assets
000000
Total non-current assets
2.26K2.84K2.32K3.65K00
Total assets
392.26K8.18M1.97M771.68K132.63K212.87K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
000000
Short term debt
002.28M000
Total current liabilities
7.45M4.17M3.80M854.54K137.96K111.28K
Non-current liabilities:
Long term debt
000000
Deferred tax
000000
Other non-current liabilities
000000
Total non-current liabilities
000000
Total liabilities
7.45M4.17M3.80M854.54K137.96K111.28K
Data sourceData sourceData source